• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

作者信息

Egger Matthias, Ekouevi Didier K, Williams Carolyn, Lyamuya Rita Elias, Mukumbi Henri, Braitstein Paula, Hartwell Tyler, Graber Claire, Chi Benjamin H, Boulle Andrew, Dabis François, Wools-Kaloustian Kara

机构信息

Division of International and Environmental Health, Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland.

出版信息

Int J Epidemiol. 2012 Oct;41(5):1256-64. doi: 10.1093/ije/dyr080. Epub 2011 May 18.

DOI:10.1093/ije/dyr080
PMID:21593078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3465765/
Abstract
摘要

相似文献

1
Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.队列简介：撒哈拉以南非洲地区评估艾滋病的国际流行病学数据库（IeDEA）
Int J Epidemiol. 2012 Oct;41(5):1256-64. doi: 10.1093/ije/dyr080. Epub 2011 May 18.
2
Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.撒哈拉以南非洲地区的艾滋病合并癫痫患者缺乏适当治疗。
Epilepsia. 2007 Jul;48(7):1424-5. doi: 10.1111/j.1528-1167.2007.01060_10.x.
3
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.瑞士HIV队列研究中的撒哈拉以南非洲移民：抗逆转录病毒治疗的可及性、疾病进展及生存情况
AIDS. 2003 Oct 17;17(15):2237-44. doi: 10.1097/00002030-200310170-00012.
4
International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019.国际撒哈拉以南非洲艾滋病流行病学数据库（IeDEA），2012-2019 年。
BMJ Open. 2020 May 15;10(5):e035246. doi: 10.1136/bmjopen-2019-035246.
5
Documenting new HIV/AIDS research and interventions in sub-Saharan Africa.记录撒哈拉以南非洲地区新的艾滋病毒/艾滋病研究及干预措施。
Afr J Reprod Health. 2013 Dec;17(4 Spec No):9-16.
6
HIV and AIDS in Africa: good news and bad news.非洲的艾滋病毒与艾滋病：好消息和坏消息
Med J Aust. 2012 Mar 19;196(5):309. doi: 10.5694/mja11.11600.
7
Cause of hospitalization and death in the antiretroviral era in Sub-Saharan Africa published 2008-2018: A systematic review.撒哈拉以南非洲地区抗逆转录病毒时代的住院和死亡原因：系统评价。
Medicine (Baltimore). 2021 Oct 29;100(43):e27342. doi: 10.1097/MD.0000000000027342.
8
Traditional health practitioners are key to scaling up comprehensive care for HIV/AIDS in sub-Saharan Africa.传统医疗从业者是在撒哈拉以南非洲扩大艾滋病毒/艾滋病综合护理的关键。
AIDS. 2004 Aug 20;18(12):1723-5. doi: 10.1097/01.aids.0000131380.30479.16.
9
Response to Birbeck et al.对伯克等人的回应
Epilepsia. 2008 Mar;49(3):541-3. doi: 10.1111/j.1528-1167.2007.01529_5.x.
10
Antiretroviral therapy in sub-Saharan Africa: evidence about need, uptake and impact from community-based cohort studies.撒哈拉以南非洲地区的抗逆转录病毒疗法：基于社区队列研究的需求、接受情况及影响的证据
Trop Med Int Health. 2012 Aug;17(8):e1-2. doi: 10.1111/j.1365-3156.2011.02947.x.

引用本文的文献

1
Cohort profile: measuring adverse pregnancy and newborn congenital outcomes (MANGO) study in Kenya.队列简介：肯尼亚测量不良妊娠和新生儿先天性结局（MANGO）研究
BMJ Open. 2025 Apr 30;15(4):e092430. doi: 10.1136/bmjopen-2024-092430.
2
Associations between nighttime or weekend deliveries and adverse maternal, birth, and neonatal outcomes: secondary analysis of the MANGO study in western Kenya.夜间或周末分娩与孕产妇、分娩及新生儿不良结局之间的关联：肯尼亚西部芒果研究的二次分析
BMC Pregnancy Childbirth. 2025 Apr 25;25(1):495. doi: 10.1186/s12884-025-07581-5.
3
Healthcare provider and patient perspectives on COVID-19 vaccination among persons with HIV, hypertension, and/or Diabetes mellitus at two regional referral hospitals in Uganda.乌干达两家地区转诊医院中医疗服务提供者和患者对艾滋病毒、高血压和/或糖尿病患者接种新冠疫苗的看法。
Discov Soc Sci Health. 2025;5(1):51. doi: 10.1007/s44155-025-00199-0. Epub 2025 Apr 14.
4
Costs analysis of integrating group interpersonal therapy into HIV care services in Senegal.在塞内加尔将团体人际治疗纳入艾滋病护理服务的成本分析。
Int J Ment Health Syst. 2025 Jan 17;19(1):4. doi: 10.1186/s13033-024-00654-6.
5
Outcomes After Loss to Follow-Up for Pregnant and Postpartum Women Living With HIV and Their Children in Kenya: A Prospective Cohort Study.肯尼亚艾滋病毒感染孕妇和产后妇女及其儿童失访后的结局：一项前瞻性队列研究。
J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):242-252. doi: 10.1097/QAI.0000000000003487. Epub 2024 Oct 7.
6
Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study.在中低收入国家，40 岁及以上 HIV 感染者中心理和物质使用障碍症状的流行情况及共病现象：一项横断面研究。
J Int AIDS Soc. 2024 Oct;27(10):e26359. doi: 10.1002/jia2.26359.
7
Association of cardiovascular disease risk with liver steatosis and fibrosis in people with HIV in low- and middle-income countries.低收入和中等收入国家HIV感染者中心血管疾病风险与肝脂肪变性和肝纤维化的关联
AIDS. 2025 Jan 1;39(1):11-21. doi: 10.1097/QAD.0000000000004012. Epub 2024 Sep 11.
8
HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST).基于多替拉韦的抗逆转录病毒治疗中 HIV-1 亚型特异性耐药性：一项多中心研究方案（DTG RESIST）。
BMJ Open. 2024 Aug 21;14(8):e085819. doi: 10.1136/bmjopen-2024-085819.
9
Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange.校正南部非洲接受抗逆转录病毒治疗的儿童和青少年的死亡率估计：多国追踪研究与健康信息交换关联之间的比较分析。
Trop Med Int Health. 2024 Aug;29(8):739-751. doi: 10.1111/tmi.14030. Epub 2024 Jul 4.
10
The effect of care interruptions on mortality in adults resuming antiretroviral therapy.护理中断对恢复抗逆转录病毒治疗的成年人死亡率的影响。
AIDS. 2024 Jul 1;38(8):1198-1205. doi: 10.1097/QAD.0000000000003859. Epub 2024 Feb 7.

本文引用的文献

1
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.校正失访导致的死亡率：适用于撒哈拉以南非洲国家抗逆转录病毒治疗项目的列线图。
PLoS Med. 2011 Jan 18;8(1):e1000390. doi: 10.1371/journal.pmed.1000390.
2
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.调整失访死亡率：撒哈拉以南非洲五个抗逆转录病毒治疗项目的分析。
PLoS One. 2010 Nov 30;5(11):e14149. doi: 10.1371/journal.pone.0014149.
3
Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy.Spectrum 中用于抗逆转录病毒治疗资格和抗逆转录病毒治疗生存的参数推导。
Sex Transm Infect. 2010 Dec;86 Suppl 2(Suppl_2):ii28-34. doi: 10.1136/sti.2010.044255.
4
Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries.评估三种采样方法，以监测中低收入国家抗逆转录病毒治疗方案的结果。
PLoS One. 2010 Nov 10;5(11):e13899. doi: 10.1371/journal.pone.0013899.
5
Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.南非自由州省等待抗逆转录病毒治疗患者的结局：前瞻性关联研究。
AIDS. 2010 Nov 13;24(17):2717-25. doi: 10.1097/QAD.0b013e32833fb71f.
6
Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.资源有限环境下感染 HIV 患者的护理保留率：新的见解和新方向。
Curr HIV/AIDS Rep. 2010 Nov;7(4):234-44. doi: 10.1007/s11904-010-0061-5.
7
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.南非成人患者接受抗逆转录病毒治疗的项目结果的时间变化，2002-2007 年。
AIDS. 2010 Sep 10;24(14):2263-70. doi: 10.1097/QAD.0b013e32833d45c5.
8
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.撒哈拉以南非洲地区开始抗逆转录病毒治疗的 HIV-1 感染者的预后：扩大治疗计划的协作分析。
Lancet. 2010 Aug 7;376(9739):449-57. doi: 10.1016/S0140-6736(10)60666-6. Epub 2010 Jul 15.
9
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.南部非洲开始抗逆转录病毒治疗的 HIV 感染儿童的早期死亡率和随访丢失。
J Acquir Immune Defic Syndr. 2010 Aug;54(5):524-32. doi: 10.1097/QAI.0b013e3181e0c4cf.
10
Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.对失访患者进行追踪对了解非洲接受抗逆转录病毒治疗的 HIV 感染者的生存决定因素具有重要影响。
Trop Med Int Health. 2010 Jun;15 Suppl 1(Suppl 1):63-9. doi: 10.1111/j.1365-3156.2010.02507.x.